References
- Hubbard RL, Marsden ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug Abuse Treatment: A National Study of Effectiveness. Chapel Hill, NC, University of North Carolina Press. 1989
- Simpson DD, Brown BS, Treatment process and outcome studies from DATOS. Drug Alcohol Depend. 1999; 57(2)
- Simpson DD, Sells SB. Opioid Addiction and Treatment: A Twelve Year Follow-up. Malabar, Fla., Robert E. Krieger Publishing Co.. 1990
- Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM.. Overview of one-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Disorders. 1997; 11: 261–278
- Simpson DD, Joe GW, Broome KM, Hiller MS, Knight K, Rowan-Szal GA.. Program diversity and treatment retention rates in the drug abuse treatment outcomes study (DATOS). Psychol Addict Behav. 1997; 11: 279–293. [CSA], [CROSSREF]
- Simpson DD, Joe GW, Brown BS.. Treatment retention and follow-up outcomes in the drug abuse treatment outcome study (DATOS). Psychol Addict Behav. 1997; 11: 297–307
- Joe GW, Simpson DD, Broome KM. Retention and patient engagement models for different treatment modalities in DATOS. Drug Alcohol Depend. 1999; 57: 113–125. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Simpson DD.. Modeling treatment process and outcomes. Addiction. 2001; 96: 207–211. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Brewer DD, Catalano RF, Haggerty K, Gainey RR, Fleming CB.. A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction. Addiction. 1998; 93: 73–92. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Anglin MD, Hser Y-I.. Treatment of drug abuse. Tonry M, Wilson JQ. Drugs and Crime. Chicago, III, University of Chicago Press. 1990; 393–458
- Broome KM, Flynn PM, Simpson DD.. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Serv Res. 1999; 34: 791–806. [PUBMED], [INFOTRIEVE], [CSA]
- McLellan AT.. Psychiatric severity as a predictor of outcome from substance abuse treatments. Meyer RE. Psychopathology and Addicitive Disorders. New York, NY, Guilford. 1986; 85–93
- McLellan AT, Alterman AL, Metzger DS, et al, Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: role of treatment services. J Consult Clin Psychol. 1994; 62: 1141–1158. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- McLellan AT, Luborsky L, Woody GE, O’Brien CP, Druley KA.. Predicting response to drug and alcohol treatments: role of psychiatric severity. Arch Gen Psychiatry. 1983; 40: 620–625. [PUBMED], [INFOTRIEVE]
- Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD.. Prognostic significance of psychiatric disorders in treated opiate addicts. Arch Gen Psychiatry. 1986; 43: 739–745. [PUBMED], [INFOTRIEVE]
- Rounsaville BJ, Tierney T, Crits-Chrisotoph K, Weissman MM, Kleber HD.. Predictors of outcome in treatment of opiate addicts: evidence for the multidimensional nature of addicts' problems. Compre Psychiatry. 1982; 23: 462–478. [CROSSREF]
- Woody GE, McLellan AT, Luborsky L. O'Brien CP. Severity of psychiatric symptoms as a predictor of benefits of psychotherapy: the VA- Penn study. Am J Psychiatry. 1984; 141: 1172–1177. [PUBMED], [INFOTRIEVE]
- Agosti V, Nunes E, Stewart JW, Quitken FM.. Patient factors related to early attrition from an outpatient cocaine research clinic: a preliminary report. Int J Addict. 1991; 26: 327–334. [PUBMED], [INFOTRIEVE]
- Joe GW, Brown BS, Simpson DD.. Psychological problems and client engagement in methadone treatment. J Nerv Ment Dis. 1995; 183: 704–710. [PUBMED], [INFOTRIEVE], [CSA]
- Hser Y-I, Grella CE, Chou CP, Anglin MD.. Relationships between drug treatment careers and outcomes: findings from the National Drug Abuse Treatment Outcome Study. Eval Rev.. 1998; 22: 496–519
- Hser Y-I, Grella CE, Hsieh S-C, Anglin MD, Brown BS.. Prior treatment experience related to process and outcomes in DATOS. Drug Alcohol Depend. 1999; 57: 137–150. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Powers KI, Anglin MD.. Cumulative versus stabilizing effects of methadone maintenance: a quasi-experimental study using longitudinal self-report data. Eval Rev. 1993; 17: 243–270
- Condelli WS, De Leon G.. Fixed and dynamic predictors of client outcomes in therapeutic communities. J Subst Abuse Treat. 1993; 10: 11–16. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Condelli WS, Hubbard RL.. Relationship between time spent in treatment and client outcomes from therapeutic communities. J Subst Abuse Treat. 1994; 11: 25–33. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Simpson DD.. The relationship of time spent in drug abuse treatment to post-treatment outcomes. Am J Psychiatry. 1979; 136: 1449–1453. [PUBMED], [INFOTRIEVE]
- Simpson DD.. Treatment for drug use: follow-up outcomes and length of time in treatment. Arch Gen Psychiatry. 1981; 38: 875–880
- Ball JC, Ross A. The Effectiveness of Methadone Maintenance Treatment. New York, Springer-Verlag. 1991
- Hoffman JA, Caudill BD, Koman JJ, Luckey JW, Flynn PM, Hubbard RL.. Comparative cocaine abuse treatment strategies: enhancing client retention and treatment exposure. J Addict Dis. 1994; 13: 115–128. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Joe GW, Simpson DD, Sells SB.. Treatment process and relapse to opioid use during methadone maintenance. Am J Drug Alcohol Abuse. 1992; 19: 124–130
- McLellan AT, Arndt IO, Woody GE, Metzger D.. Psychosocial services in substance abuse services? A dose-ranging study of psychosocial services. JAMA. 1993; 269: 1953–1959. [PUBMED], [INFOTRIEVE], [CROSSREF]
- McLellan AT, Grissom GR, Brill P, Durell J, Metzger DS, O'Brien CP.. Private substance abuse treatments: are some programs more effective than others?. J Subst Abuse Treat. 1993; 10: 243–254. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shoptaw S, Rawson RA, McCann MJ, Obert JL.. The Matrix Model of outpatient stimulant abuse treatment: evidence of efficacy. J Addict Dis. 1994; 13: 129–141. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Brown BS, O'Grady KE, Battjes RJ, Farrell EV, Smith NP, Nurco DN.. Effectiveness of a stand-alone aftercare program for drug-involved offenders. J Subst Abuse Treat. 2001; 21: 185–192. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hawkins JD, Catalano RF.. Aftercare in drug abuse treatment. Int J Addict. 1985; 20: 917–945. [PUBMED], [INFOTRIEVE]
- Inciardi JA.. HIV risk reduction and service delivery strategies in criminal justice settings. J Subst Abuse Treat. 1996; 13: 421–428. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Inciardi JA, Marin SS, Butzin CA, Hooper RM, Harrison LD.. An effective model of prison-based treatment for drug-involved offenders. J Drug Issues. 1997; 27: 261–278. [CSA]
- Knight K, Simpson DD, Hiller ML.. Three-year reincarceration outcomes for therapeutic community treatment in Texas. Prison Journal. 1999; 79: 337–351
- Martin SS, Butzin CA, Saum CE, Inciardi JA.. Three-year outcomes of therapeutic community treatment for drug-involved offenders in Delaware: from prison to work release to aftercare. Prison Journal. 1999; 79: 294–320
- McAuliffe WE, Chien JMN.. Recovery training and self-help: a relapse prevention program for treated heroin addicts. J Subst Abuse Treat. 1986; 3: 9–20. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wexler HK, Melnick G, Lowe L, Peters J.. Three-year reincarceration outcomes for Amity in-prison therapeutic community and aftercare in California. Prison Journal. 1999; 79: 321–336
- Goehl L, Nunes E, Quitkin F, Hilton I.. Social networks and methadone treatment outcome: the costs and benefits of social ties. Am J Drug Alcohol Abuse. 1993; 19: 251–262. [PUBMED], [INFOTRIEVE], [CSA]
- Havassy BE, Hall SM, Wasserman DA.. Social support and relapse: commonalities among alcoholics, opiate users, and cigarette smokers. Addict Behav. 1991; 16: 235–246. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Havassy BE, Hall SM, Wasserman DA.. Social relationships and abstinence from cocaine in an American treatment sample. Addiction. 1995; 90: 699–710. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hawkins JD, Fraser MW.. The social networks of drug uses before and after treatment. Int J Addict. 1987; 22: 343–353. [PUBMED], [INFOTRIEVE], [CSA]
- Waldorf D.. Natural recovery from opiate addiction: some social-psychological processes of untreated recovery. J Drug Issues. 1983; 13: 237–280
- Broome KM, Simpson DD, Joe GW.. The role of social support following short-term inpatient treatment. Am J Addict. 2002; 11: 57–65. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hser Y-I, Grella CE, Hsieh SC, Anglin MD, Brown BS.. Prior treatment experience related to process and outcomes in DATOS. Drug Alcohol Depend. 1999; 57: 137–150. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hanlon TE, Nurco DN, Bateman RW. O'Grady KE. The response of drug abuser parolees to a combination of treatment and intensive supervision. Prison Journal. 1998; 78: 31–34
- Gogineni A, Stein MD, Friedmann PD.. Social relationships and intravenous drug use among methadone maintenance patients. Drug Alcohol Depend. 2001; 64: 47–53. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Pivnick A, Jacobsen A, Eric K, Doll L, Drucker E.. AIDS, HIV infections and illicit drug use within inner-city families and social networks. Am J Public Health. 1994; 84: 271–274. [PUBMED], [INFOTRIEVE], [CSA]
- Corrington JE.. Spirituality and recovery: relationship between levels of spirituality, contentment, and stress during recovery from alcoholism in A.A.. Alcoholism Treatment Quarterly. 1989; 64: 151–160
- Nealon-Woods MA, Ferrari JR, Jason LA.. Twelve-step program use among Oxford House residents: spirituality or social support in sobriety?. J Subst Abuse. 1995; 7: 311–318. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Peteet JR.. A closer look at the role of a spiritual approach in addictions treatment. J Subst. Abuse Treat. 1993; 10: 263–267. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Warfield RD, Goldstein MB.. Spirituality: the key to recovery from alcoholism. Counseling and Values. 1996; 40: 196–205
- Pardini DA, Plante TG, Sherman A, Stump JE.. Religious faith and spirituality in substance abuse recovery: determining the mental health benefits. J Subst Abuse Treat. 2000; 19: 347–354. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Simpson DD, Chatham LR. TCU/DATAR Forms Manual. Fort Worth, Tex., Institute of Behavioral Health. 1995
- Derogatis LR, Rickels K, Rock AF.. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br J Psychiatry. 1976; 128: 280–289. [PUBMED], [INFOTRIEVE]
- Beck AT, Steer RA. Manual for the Beck Hopelessness Scale. San Antonio, Tex., Psychological Corporation. 1988
- Hawkins JD, Catalano RF.. Aftercare in drug abuse treatment. Int J Addict. 1985; 20: 917–945. [PUBMED], [INFOTRIEVE]
- Simpson DD, Wexler HK, Inciardi JA, Drug treatment outcomes for correctional settings, Part One. [Special Issue]. Prison Journal. 1999; 79: 291–368
- McLellan AT.. Have we evaluated addiction treatment correctly? Implications from a chronic care perspective. Addiction. 2002; 97: 249–252. [PUBMED], [INFOTRIEVE], [CROSSREF]
- McLellan AT, O'Brien CP, Lewis D, Kleber HD. Drug addiction as a chronic medical illness: implications for treatment, insurance, and evaluation. JAMA. 2000; 284: 1689–1695
- Crape BL, Latkin CA, Laris AS, Knowlton AR.. The effects of sponsorship in twelve-step treatment of injection drug users. Drug Alcohol Depend. 2002; 65: 291–301. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]